/** blogpostTitle: "Fine Organic Industries: A flat FY27, while global expansion moves into execution" */

Fine Organic Industries: A flat FY27, while global expansion moves into execution

Fine Organic Industries entered FY26 with a familiar mix of strengths and constraints. The platform remains diversified across end uses and geographies, but capacity is tight. FY26 numbers showed steady revenue growth, while margins reflected raw material inflation and logistics disruption.

On a consolidated basis, revenue from operations rose 4.3% year-on-year to INR 2,365.8 crore in FY26 (FY25: INR 2,269.1 crore). EBITDA came in at INR 483.0 crore with a 20.4% margin (FY25: INR 512.9 crore, 22.6% margin). PAT was INR 417.1 crore, up 1.6% year-on-year (FY25: INR 410.5 crore). The March quarter showed a sequential recovery in profitability, helped by operating leverage, but management commentary remained cautious on costs.

The company’s investor presentation highlighted exports at 55% of revenue in Q4 FY26 and for FY26, with domestic at 45%. Management described demand as stable through the year, with better domestic performance and steady exports. The pressure point was costs. The company flagged higher raw material prices and a Q4 freight uptick linked to the West Asia crisis.

FY26 performance: stable demand, cost pressures show up in margins

For Q4 FY26, consolidated revenue was INR 625.3 crore versus INR 606.8 crore in Q4 FY25. EBITDA was INR 129.8 crore (20.8% margin) versus INR 119.6 crore in the year-ago quarter. PAT rose to INR 117.5 crore from INR 97.1 crore.

Standalone numbers were softer at the full-year level. Standalone FY26 revenue was INR 2,276.0 crore versus INR 2,205.2 crore in FY25. Standalone EBITDA declined to INR 411.4 crore (18.1% margin) from INR 481.1 crore in FY25, and standalone PAT declined to INR 346.4 crore from INR 389.7 crore.

Management linked margin pressure to input inflation, describing vegetable oil feedstocks as volatile. In the call, the Chairman pointed to crude-linked effects and biodiesel blending policies that could reduce palm oil availability, keeping prices elevated. Freight had largely stabilised for much of the year but rose again in Q4 due to West Asia disruption. Importantly, the company indicated customers in affected regions accepted buying on FOB terms, taking incremental freight risk.

Financial summary (consolidated)

Capacity constraints are driving a clear near-term message

A key takeaway from the earnings call was blunt capacity reality. Management stated that all plants are running at almost full capacity. As a result, they expect FY27 to be flat, and that growth is likely to remain flat until the JNPA SEZ plant is commissioned. Management clarified that any topline movement in the interim could be price-led rather than volume-led.

The same realism came through on profitability expectations. Management stated that FY23’s unusually high profitability was driven by post-COVID supply chain disruption and inventory advantages. They suggested investors should not treat FY23 as a benchmark. Instead, management indicated a sustainable EBITDA range of 18% to 20% based on longer-term history.

This matters because it sets expectations around the operating model. Fine Organics positions its products as performance additives used in very small dosages, and management argued that demand does not drop meaningfully even as prices rise, because the additive’s value contribution is high versus its share of the end product.

Expansion agenda: SEZ in India, US manufacturing, and a strategic Malaysia step

FY26 was described as an important year for Fine Organics’ global expansion agenda, with multiple initiatives moving in parallel.

India: JNPA SEZ as the main growth unlock

The company reiterated that the SEZ facility is a critical pillar of the long-term strategy, designed to strengthen export manufacturing capabilities and create room at existing facilities for domestic growth. During FY26, the wholly owned subsidiary issued preference shares of INR 65 crore, and management stated total investment in the subsidiary stands at about INR 192.5 crore to date.

On timelines, management expects commercial production during FY28 and stated in the call that they believe the plant will start in the second half of 2028. The initial plan is pragmatic: produce products already exported today, enabling exports to start quickly after commissioning. Management also indicated that product approvals should not be a major bottleneck, though a few large customers may conduct formal audits due to the change in manufacturing site.

United States: phased build with execution caution

Fine Organics incorporated Fine Organics Americas LLC in Q1 FY26 and invested about USD 1.12 million (around INR 9.6 crore), acquiring around 160 acres of land in South Carolina. Management positioned the US as strategically important for serving North, Central and South America, and for improving supply chain security.

However, management also emphasised a cautious first phase. The company wants to start with a conservative Phase 1 because it has limited experience operating a manufacturing plant in the US. Once construction begins, management expects commissioning in 18 to 24 months, aiming for 18 months.

Malaysia: proposed 80% acquisition to deepen palm-based positioning

The board approved the proposal to acquire up to 80% of Oleofine Organics Sdn. Bhd. in Malaysia for about MYR 34.2 million (around INR 82.9 to 83 crore). On the call, management stated the target’s turnover was about MYR 23.3 million as of January 31, 2026, and corrected an earlier INR conversion in the transcript to roughly INR 54 crore.

Management described the acquisition as strategic because the target’s portfolio is palm-based. Malaysia offers an advantage in palm and palm kernel feedstocks, which India lacks. The transaction is expected to be completed within about three months from the call date, subject to approvals and definitive agreements. The call also noted that 50% of the stake would be acquired from Smoothtex Chemicals Pvt. Ltd., described as a promoter group entity, and the company stated the transaction would be at arm’s length.

Dubai and Thailand: local presence and sequencing discipline

The company incorporated Fine Organics FZE in Dubai in Q3 FY26 and infused AED 200,000 (about INR 49.5 lakh) in Q4 FY26. The purpose is to build presence in GCC markets and improve supply chain efficiency.

In Thailand, Fine Organics infused THB 22.5 million (about INR 6.17 crore) into its joint venture during Q3 FY26. Management said the Thailand plant is running at full scale and expansion is intended, but execution is being deferred due to limited internal bandwidth while the SEZ project remains the top priority.

What investors should track from here

The FY26 disclosures do not provide a segment revenue breakdown, but the presentation reiterates the company’s broad exposure across food additives, polymer additives, CosPha, coatings, feed nutrition and other specialty applications. The business remains diversified in customer footprint as well, with the company reporting 600+ products, 950+ direct customers, and presence across 110+ countries as of March 31, 2026.

The near-term investment narrative is now more important than incremental quarterly growth. Management’s commentary points to three practical monitoring points.

First is project execution. The company is running multiple initiatives and management explicitly acknowledged the manpower constraint, choosing to protect the SEZ timeline by deferring Thailand expansion.

Second is cost volatility. Vegetable oil feedstocks and freight remain key swing factors, and management does not expect raw material prices to ease materially in the near term.

Third is the integration value of Malaysia and the ramp strategy in the US. The Malaysia acquisition is small in current revenue terms, but management framed it as a long-term strategic step for palm-based specialty products.

Fine Organics ended FY26 with stable demand, improving quarter-on-quarter profitability, and a clear statement that FY27 is likely to be flat due to capacity. The investment cycle is set to define the next two years, with SEZ commissioning in FY28 positioned as the primary trigger for the next growth phase.